Summary: Applied Pharmacoeconomic and Outcomes Research Forum
The second Southern California Applied Pharmacoeconomic and Outcomes Research Forum
was held October 16th
on the University of California San Diego campus. The event was hosted
by the Skaggs School of Pharmacy and Pharmaceutical Sciences and supported by a grant
Attendees of the Forum represented Managed Care Organizations, Government Agencies,
Medical Centers, Academia, and Pharmaceutical and Biotech companies in Southern California.
Each attendee was invited because they had a demonstrated interest in expanding the practical
application of pharmacoeconomic and outcomes research to enhance decision-making.
"Biologics: Drawing (or Crossing) the line of Cost vs. Benefit? A Case in Oncology
The case, prepared by Margaret Stull, PharmD, Pharmacoeconomic Clinical Specialist at the
VA San Diego Healthcare System, was for a hypothetical new biologic agent - Expenzumab
(VegitinTM) - indicated for first-line treatment of metastatic colorectal carcinomas.
Three speakers commented from their institution's perspective regarding issues they may face if
evaluating and managing Expenzumab within their health care system.